Ireland vs New Zealand: Proportion of isolates with decreased susceptibility or resistance
Ireland
0
in 2020
New Zealand
0.1
in 2020
Ireland rank
13th
New Zealand rank
11th
Proportion of isolates with decreased susceptibility or resistance over time
- Ireland
- New Zealand
How they compare
New Zealand currently reports 0.1 against 0 in Ireland, a difference of 0.1.
The two have swapped places 2 times across 8 shared years of data; in 2010 it was New Zealand ahead.
Ireland ranks 13th and New Zealand ranks 11th of 52 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ireland | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1786 | 0.3779 | 0.1993 | New Zealand |
| 2020s | 0 | 0.1 | 0.1 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Ireland or New Zealand?
- New Zealand, at 0.1 against 0 in Ireland as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Ireland and New Zealand?
- 0.1, with New Zealand ahead.
- How many years of comparable data are there for Ireland and New Zealand?
- 8 years are reported by both, from 2010 to 2020.
- How do Ireland and New Zealand rank globally for proportion of isolates with decreased susceptibility or resistance?
- Ireland ranks 13th and New Zealand ranks 11th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.